Astellas’ Once-Daily Tacrolimus Gets Nod From Europe’s CHMP
This article was originally published in The Pink Sheet Daily
Executive Summary
Positive opinion comes after FDA issued a mix of “approvable” and “not approvable” decisions for three transplant claims.